Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model | Zendy

Irene Yu Lubenko | Zendy; Ele. Strukova | Zendy; Maria V. Smirnova | Zendy; Sergey N. Vostrov | Zendy; Yury A. Portnoy | Zendy; Stephen H. Zinner | Zendy; Alexander A. Firsov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model

Author(s) -

Irene Yu Lubenko,

Ele. Strukova,

Maria V. Smirnova,

Sergey N. Vostrov,

Yury A. Portnoy,

Stephen H. Zinner,

Alexander A. Firsov

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn288

Subject(s) - staphylococcus aureus , pharmacodynamics , vancomycin , microbiology and biotechnology , minimum inhibitory concentration , antibiotics , methicillin resistant staphylococcus aureus , area under the curve , pharmacokinetics , medicine , pharmacology , biology , bacteria , genetics

The aim of this study was to compare the pharmacodynamics of telavancin (TLV) and vancomycin (VAN) with Staphylococcus aureus. Their concentrations were simulated between the MIC and the mutant prevention concentration (MPC), and above the MPC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research